Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

ConditionsDry EyeCataract
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorJin Yang

About this trial

This prospective single-center study evaluates the effect of dry eye disease and short-term ocular surface treatment on the agreement and repeatability of corneal astigmatism measurements in patients with age-related cataract. Participants undergoing preoperative cataract evaluation are classified into a control group or a dry eye disease group according to ocular surface symptoms and objective tear film findings.

All participants undergo ocular surface assessment and repeated corneal measurements using three commonly used devices: IOLMaster 700, Pentacam AXL, and iTrace Prime. Measurements include keratometric corneal astigmatism, total corneal astigmatism, and vector components of astigmatism. Patients with dry eye disease receive 0.3% sodium hyaluronate eye drops four times daily for 2 weeks, after which ocular surface assessment and device measurements are repeated.

The primary objective is to determine whether dry eye disease reduces interdevice agreement and test-retest repeatability of corneal astigmatism measurements, and whether short-term ocular surface treatment improves measurement stability. Interdevice agreement is assessed using Bland-Altman analysis, and repeatability is evaluated using within-subject standard deviation, test-retest repeatability, and intraclass correlation coefficient.

Eligibility criteria

Qualifiers

Patients with age-related cataract undergoing preoperative ocular examination.

Ability to complete ocular surface evaluation, including the Ocular Surface

Disease Index questionnaire, non-invasive tear film break-up time, tear meniscus height, Schirmer test, and ocular surface staining.

Ability to complete repeated corneal astigmatism measurements using IOLMaster 700, Pentacam AXL, and iTrace Prime.

Disqualifiers

Previous ocular surgery or ocular trauma.

Corneal degeneration, corneal dystrophy, or other corneal diseases that could affect corneal measurements.

Active corneal or conjunctival infection.

Uveitis.

Trial design

Treatments tested in this trial

  • Sodium Hyaluronate Eye Drops

Treatment groups

400 Participants
are divided into 2 treatment groups

Locations

1
Eye and ENT hospital of Fudan University200000, ShanghaiShanghai Municipality, China

Sponsors and collaborators

Jin Yang

Lead sponsor

Eye & ENT Hospital of Fudan University

Sponsor institution